Chemotherapy influences inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) activity on 3D breast cancer cell line

Oncology Research

Volumn 16, Issue 4, 2006, Pages 195-203

  Öktem, Gulperi ^a   Bilir, A ^b   Selvi, N ^a   Yurtseven, M E ^a   Vatansever, S ^c   Ates, U ^a   Uysal, A ^a   Omay, S B ^d  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c CELAL BAYAR UNIVERSITY   (Turkey)

^d KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Chemotherapy; eNOS; iNOS

Indexed keywords

BROXURIDINE; DOCETAXEL; DOXORUBICIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 33751005010     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981107     Document Type: Article

References (41)

1. Yuhas, J. M.; Li, A. P.; Martinez, A. O. A simplified method for production and growth of multicellular tumor spheroids. Cancer Res. 37:36-39; 1979.
2. Erlichman, C.; Tannock, I. F. Growth and characterization of multicellular tumor spheroids of human bladder carcinoma origin. In Vitro Cell Dev. Biol. 22:449; 1986.
3. Knuchel, R.; Keng, P.; Hofstadter, F. Differentiation patterns in two- and three-dimensional culture systems of human squamous carcinoma cell lines. Am. J. Pathol. 3:725; 1990.
4. Knuchel, R.; Mecki, S.; Masters, J. R. Verteilungsmuster Urothelassoziierter Glycoprotein an in vitro Kulturen humaner Harnblasenkarzinomzellinien. Verh. Dtsch. Ges. Pathol. 77:256; 1993.
5. Dodd, L. G.; Kerns, B. J.; Dodge, R. K.; Layfield, L. J. Intratumoral heterogeneity in primary breast carcinoma: Study of concurrent parameters. J. Surg. Oncol. 64:280-288; 1997.
6. Sutherland, R. M.; Eddy, H. A.; Bareham, B.; Reich, K.; Vanantwerp, D. Resistance to adriamycin in multicellular spheroids. Int. J. Radiat. Oncol. Biol. Phys. 5(8):1225-1230; 1979.
7. Erlanson, M.; Daniel-Szolgay, E.; Carlsson, J. Relations between the penetration, binding and average concentration of cytostatic drugs in human tumor spheroids. Cancer Chemother. Pharmacol. 9(5):343-353; 1992.
8. Nicholson, K. M.; Bibby, M. C.; Phillips, R. M. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Eur. J. Cancer 33(8):1291-1298; 1997.
9. Reveneau, S.; Lourent, A.; Genevie, J.; Hilbert, S. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab. Invest. 79:1215-1225; 1999.
10. Knowles, R. G.; Moncada, S. Nitric oxide synthase in mammals. Biochem. J. 298:249-258; 1994.
11. Thomsen, L. L.; Miles, D. W. Role of nitric oxide in tumor progression: Lessons from human tumors. Cancer Metastasis Rev. 17:107-118; 1998.
12. Albina, J.; Cui, S.; Mateo, R. B.; Reichner, S. J. Nitric oxide mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080-5085; 1993.
13. Oktem, G.; Karabulut, B.; Selvi, N.; Sezgin, C.; Sanli, U. A.; Uslu, R.; Yurtseven, M. E.; Omay, S. B. Differential effects of doxorubicin and docetaxel on nitric oxide production and inducible nitric oxide synthase expression in MCF-7 human breast cancer cells. Oncol. Res. 14:381-386; 2004.
14. Wartenberg, M.; Schallenberg, M.; Hescheler, J. R.; Sauer, H. Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids. Int. J. Cancer 104:274-282; 2003.
15. Thomsen, L. L.; Miles, D. W.; Happerfield, L.; Bobrow, L. G.; Knowles, R. G.; Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72:41-44; 1995.
16. Jenkins, D. C.; Charles, I. G.; Thomsen, L. L.; Moss, D. W.; Holmes, L. S.; Baylis, S. A. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92:4392-4396; 1995.
17. Tschugguel, W.; Schneeberger, C.; Unfried, G.; Czerwenka, K.; Weninger, W.; Mildner, M. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res. Treat. 56:145-151; 1999.
18. Chinje, E. J.; Stratford, I. J. Role of nitric oxide in growth of solid tumors: A balancing act. Essays Biochem. 32:61-72; 1997.
19. Stuehr, D. J.; Kwon, N. S.; Nathan, C. F.; Griffith, O. W.; Feldman, P. L.; Wiseman, J. N-omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266(10):6259-6263; 1991.
20. Young-Myong, K.; Bombeck, C. T.; Biliar, R. T. Nitric oxide as a bifuctional regulator of apoptosis. Circ. Res. 84:253-256; 1999.
21. Rajnakova, A.; Goh, P. M.; Chan, S. T. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 18:1841-1845; 1997.
22. Martin, J. H.; Begum, S.; Alalami, O.; Harrison, A.; Scott, K. W. Endothelial nitric oxide synthase: Correlation with histological grade, lymph node status and estrogen receptor expression in human breast cancer. Tumor Biol. 21(2):90-97; 2000.
23. Aoki, E.; Takeuchi, I. K.; Shoji, R. Nitric oxide: An attractive signaling molecule. Acta Histochem. Cytochem. 28:97-106; 1995.
24. Keller, R.; Geiges, M.; Keist, R. L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res. 50:1421-1425; 1990.
25. Martin, J. H.; Edwards, S. W. Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J. Immunol. 150:3478-3486; 1993.
26. MacRitchie, A. N.; Jun, S. S.; Chen, Z.; German, Z.; Yuhanna, I. S.; Sherman, T. S.; Shaul, P. W. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ. Res. 81(3):355-362; 1997.
27. Wink, D. A.; Cook, J. A.; Christodoulou, D.; Krishna, M. C.; Pacelli, R.; Kim, S.; DeGraff, W.; Gamson, J. Nitric oxide and some nitric oxide donor compounds enhance the cytotoxicity of cisplatin. Nitric Oxide 1(1):88-94; 1997.
28. Azizzadeh, B.; Yip, H. T.; Blackwell, K. E.; Horvath, S.; Calcaterra, T. C.; Buga, G. M.; Ignarro, L. J.; Wang, M. B. Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 111:1896-1900; 2001.
29. Cook, J. A.; Krishna, M. C.; Pacelli, R.; DeGraff, W.; Liebmann, J.; Mitchell, J. B.; Russo, A.; Wink, D. A. Nitric oxide enhancement of melphalan-induced cytotoxicity. Br. J. Cancer 76:325-334; 1997.
30. Adams, D. J.; Levesque, M. C.; Weinberg, J. B.; Smith, K. L.; Flowers, J. L.; Moore, J.; Colvin, O. M.; Silber, R. Nitric oxide enhancement of fludarabine cytotoxicity for B-CLL lymphocytes. Leukemia 15:1852-1859; 2001.
31. Becker, J. L.; Prewett, T. L.; Spaulding, G. F.; Goodwin, T. J. Three-dimensional growth and differentiation of ovarian tumor cell line in high aspect rotating-wall vessel: Morphologic and embryologic considerations. J. Cell. Biochem. 51:283-289; 1993.
32. Lind, D. S.; Kontaridis, M. I.; Edwards, P. D.; Josephs, M. D.; Moldawer, L. L.; Copeland, 3rd, E. M. Nitric oxide contributes to adriamycin antitumor effect. J. Surg. Res. 69:283-287; 1997.
33. Jung, I. D.; Lee, J. S.; Yun, S. Y.; Park, C. G.; Han, J. W.; Lee, H. W.; Lee, H. Y. Doxorubicin inhibits the production of nitric oxide by colorectal cancer cells. Arch. Pharm. Res. 25:691-696; 2002.
34. Gallo, O.; Masini, E.; Morbidelli, L.; Franchi, A.; Fini-Storchi, I.; Vergari, W. A.; Ziche, M. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. Natl. Cancer Inst. 90:587-596; 1998.
35. Korff, T.; Augustin, H. G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143:1341-1352; 1998.
36. Korff, T.; Augustin, H. G. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J. Cell Sci. 112:3249-3258; 1999.
37. Korff, T.; Kimmina, S.; Martiny-Baron, G.; Augustin, H. G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J. 15:447-457; 2001.
38. Haspel, H. C.; Scicli, G. M.; McMahon, G.; Scicli, A. G. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc. Res. 63(3):304-315; 2002.
39. Starzec, A.; Briane, D.; Kraemer, M.; Kouyoumdjian, J. C.; Moretti, J. L.; Beaupain, R.; Oudar, O. Spatial organization of three-dimensional cocultures of adriamycin-sensitive and resistant human breast cancer MCF-7 cells. Biol. Cell 95(5):257-264; 2003.
40. Shackleton, M.; Vaillant, F.; Simpson, K. J.; Stingl, J.; Smyth, G. K.; Asselin-Labat, M. L. Generation of a functional mammary gland from a single stem cell. Nature 439:84-88; 2006.
41. Due-nas-Gonzalez, A.; Isales, C. M.; del Mar Abad-Hernandez, M.; Gonzalez-Sarmiento, R.; Sangueza, O.; Rodriguez-Commes, J. Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol. 10:645-649; 1997.